Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain

References

• Olaguibel JM, Quirce S, Juliá B, et al.; on behalf of the MAGIC Study Group. Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res. 2012;13:50.
   PubMed Web of Science ®Google Scholar
• Guía española para el manejo del asma (GEMA 4.2). Versión 2017 [cited 2018 Jan]. Available from: https://www.gemasma.com
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Aumann I, Prenzler A, Welte T, et al. Epidemiology and costs of asthma in Germany - a systematic literature review. Pneumologie. 2014;68:557–567.
   PubMedGoogle Scholar
• Hekking PP, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135:896–902.
   PubMed Web of Science ®Google Scholar
• Cisneros Serrano C, Melero Moreno C, Almonacid Sánchez C, et al. Guidelines for severe uncontrolled asthma. Arch Bronconeumol. 2015;51:235–246.
   PubMed Web of Science ®Google Scholar
• Quirce S, Plaza V, Picado C, et al. Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain. J Investig Allergol Clin Immunol. 2011;21:466–471.
   PubMed Web of Science ®Google Scholar
• Walsh CJ, Zaihra T, Benedetti A, et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin Exp Allergy. 2016;46:1291–1302.
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2:741–750.
   PubMed Web of Science ®Google Scholar
• Chiappori A, De Ferrari L, Folli C, et al. Biomarkers and severe asthma: a critical appraisal. Clin Mol Allergy. 2015;13:20.
   PubMedGoogle Scholar
• Martínez-Moragón E, Serra-Batllés J, de Diego A, et al. Coste económico del paciente asmático en España (estudio AsmaCost). Arch Bronconeumol. 2009;45:481–486.
   PubMed Web of Science ®Google Scholar
• Ismaila AS, Sayani AP, Marin M, et al. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med. 2013;13:70.
   PubMed Web of Science ®Google Scholar
• Gadenne S, Pribil C, Chouaid C, et al. The costs of asthma in France and the economic implications of its level of control. Rev Mal Respir. 2011;28:419–426.
   PubMed Web of Science ®Google Scholar
• Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, et al. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20:11–23.
   PubMed Web of Science ®Google Scholar
• Lamberts H, Wood M, Hofmans-Okkes ÍM, editors. The International Classification of Primary Care in the European Community. With a multi-language layer. Oxford: Oxford University Press; 1993.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Sicras-Mainar A, Navarro-Artieda R. Adjusted clinicals groups: a patient classification system through risk adjustment. Rev Peru Med Exp Salud Publica. 2013;30:308–314.
   PubMedGoogle Scholar
• The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD): World Health Organization [cited 2017 Jul 10]. Available from: http://www.who.int/classifications/atcddd/en/
   Google Scholar
• Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–461.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística (INE). 2014. Encuesta de costes laborales del año 2014 [cited 2017 Apr]. Available from: http://www.ine.es/infoine
   Google Scholar
• Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320:1197–1200.
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017;22:651–661.
   PubMed Web of Science ®Google Scholar
• Von Bülow A, Kriegbaum M, Backer V, et al. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2:759–767.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–323.
   PubMed Web of Science ®Google Scholar
• Campo P, Rodríguez F, Sánchez-García S, et al. SEAIC Asthma Committee. Severe asthma workgroup; SEAIC asthma committee. Phenotypes and endotypes of uncontrolled severe asthma: new treatments. J Investig Allergol Clin Immunol. 2013;23:76–88.
   PubMed Web of Science ®Google Scholar
• Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, et al. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study. Respir Med. 2019;151:49–54.
   PubMed Web of Science ®Google Scholar
• Stirbulov R, Lopes da Silva N, Maia SC, et al. Cost of severe asthma in Brazil-systematic review. J Asthma. 2016;53:1063–1070.
   PubMed Web of Science ®Google Scholar
• Accordini S, Corsico AG, Braggion M, et al. Therapy and Health Economics Working Group of the European Community Respiratory Health Survey II. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160:93–101.
   PubMed Web of Science ®Google Scholar
• Chastek B, Korrer S, Nagar SP, et al. Economic burden of illness among patients with severe asthma in a managed care setting. JMCP. 2016;22:848–861.
   PubMedGoogle Scholar
• Melero Moreno C, Quirce S, Huerta A, et al. Economic impact of severe asthma in Spain: multicentre observational longitudinal study. J Asthma. 2018;9:1–11.
   Google Scholar